BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Abdullah Sakin, Suleyman Sahin, Muhammed Mustafa atci, Cumhur Demir, Nurgul Yasar, Caglayan Geredeli, Sener Cihan. The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance statusJournal of Oncological Sciences 2019;  doi: 10.1016/j.jons.2019.08.003
2
Sara Pusceddu, Michele Ghidini, Martina Torchio, Francesca Corti, Gianluca Tomasello, Monica Niger, Natalie Prinzi, Federico Nichetti, Andrea Coinu, Maria Di Bartolomeo, Mary Cabiddu, Rodolfo Passalacqua, Filippo de Braud, Fausto Petrelli. Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-AnalysisCancers 2019; 11(4): 484 doi: 10.3390/cancers11040484